Patents by Inventor Yusri A. ELSAYED

Yusri A. ELSAYED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY USING A MALT1 INHIBITOR AND A BTK INHIBITOR
    Publication number: 20220288058
    Abstract: The invention relates to a method of treating a disorder or condition that is affected by the inhibition of MALT1 in a subject in need of treatment, comprising administering a BTK inhibitor and a therapeutically effective dose of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A): or a solvate or pharmaceutically acceptable salt form thereof to said subject, wherein said therapeutically effective dose is defined in the specification.
    Type: Application
    Filed: March 1, 2022
    Publication date: September 15, 2022
    Inventors: Anthony T. GREWAY, Ulrike PHILIPPAR, Bieke VERBIST, Thomas C. WILDE, Marie E. WILLEMIN, Yusri A. ELSAYED, John GERECITANO
  • 4-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE FOR THE TREATMENT OF HODGKIN'S LYMPHOMA
    Publication number: 20160015700
    Abstract: The present invention is directed to methods for the treatment of Hodgkin's lymphoma comprising administering to a patient in need thereof, a therapeutically effective amount of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6 -(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide as mono-therapy or as combination or co-therapy with one or more chemotherapeutic agent or chemotherapy regimens.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 21, 2016
    Inventors: Carla DE BOER, Yusri A. ELSAYED, Imran KHAN, Carl L. MANTHEY, Linda SNYDER